By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Following on last week's announcement of preliminary financial results, Clinical Data today reported flat fourth-quarter revenue growth and an increased net loss on higher R&D spending.

The Newton, Mass.-based firm reported a 26 percent increase in its full-year revenues compared to fiscal-year 2009 and sharp decrease in its net loss year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.